Veloxis Pharmaceuticals Receives Approval from USAN for “Pegrizeprument” as Nonproprietary Name for VEL-101
CARY, N.C., Feb. 25, 2025 /PRNewswire/ -- Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company and an Asahi Kasei company, has announced that the United States Adopted Name (USAN)